The five-year extension of the exclusive silicone supply agreement removes a key overhang on manufacturing continuity. Monitor the next 10-Q for any changes in gross margin or inventory levels that might reflect the revised pricing terms.
Price Chart
Executive Summary
Establishment Labs extended its exclusive medical-grade silicone supply agreement with NuSil Technology through December 31, 2031, with automatic one-year renewals. The amendment also revised payment terms to Net 30 EOM, added a joint IP framework, updated pricing tables (redacted), and imposed a credit limit (redacted). This is a routine supply-chain extension with no financial figures disclosed — the exclusivity and term extension are operationally positive but lack quantifiable impact.
Key Facts
- Amendment No. 3 extends the initial term of the Master Supply Agreement from December 31, 2026 to December 31, 2031.
- The agreement provides for automatic one-year renewals for up to five successive terms unless either party gives notice by December 31 of the prior year.
- Payment terms changed to Net 30 EOM (payment due 30 calendar days after the last day of the invoice month).
- Buyer (Establishment Labs) must purchase substantially all of its silicone material requirements exclusively from NuSil.
- A credit limit on unsecured credit extended by NuSil to Buyer was added (amount redacted).
- A last-time buy right was added in the event of a Change in Control of NuSil, capped at the prior [***] period's purchases.
- Pricing tables and certain commercial terms remain redacted as confidential.
Financial Impact
No financial figures disclosed — pricing, credit limit, and volume commitments are redacted. The extension secures a critical supply chain for five additional years but no dollar amounts are available.
Risk Factors
- Redacted pricing terms could include unfavorable cost adjustments that pressure margins.
- The credit limit (redacted) may constrain working capital if demand accelerates.
- Exclusivity limits flexibility to source alternative silicone suppliers.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-115928 |
| Document: tm2627633d1_ex10-1.htm | 0001104659-26-115928 |
| Document: 0001104659-26-115928-index-headers.html | 0001104659-26-115928 |
| Document: 0001104659-26-115928-index.html | 0001104659-26-115928 |
| Document: 0001104659-26-115928.txt | 0001104659-26-115928 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | 8-K | $61.36 | awaiting T+60 | — | $66.95 (+9.11%) |
Aug 6, 2026 11w ago | 8-K | $79.05 | awaiting T+60 | — | $66.95 (−15.31%) |
Jun 29, 2026 17w ago | 3 | $85.81 $67.76 | ▼ −21.03% | ▼ −23.85% | $66.95 (−21.98%) |
Jun 29, 2026 17w ago | 8-K | $87.42 $70.24 | ▼ −19.65% | ▼ −24.04% | $66.95 (−23.42%) |
May 6, 2026 24w ago | 8-K | $74.54 $92.54 | ▲ +24.15% | ▲ +22.09% | $66.95 (−10.18%) |
May 6, 2026 24w ago | Insider Cluster | $74.54 $92.54 | ▼ −24.15% | ▼ −22.09% | $66.95 (+10.18%) |
Apr 24, 2026 26w ago | DEFA14A | $65.47 $93.87 | ▲ +43.38% | ▲ +38.60% | $66.95 (+2.26%) |
Apr 10, 2026 28w ago | DEFA14A | $62.92 $87.99 | ▲ +39.84% | ▲ +30.92% | $66.95 (+6.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers